These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30068801)

  • 1. Synthesis and Evaluation of Fuligocandin B Derivatives with Activity for Overcoming TRAIL Resistance.
    Arai MA; Masuda A; Suganami A; Tamura Y; Ishibashi M
    Chem Pharm Bull (Tokyo); 2018; 66(8):810-817. PubMed ID: 30068801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production.
    Hasegawa H; Yamada Y; Komiyama K; Hayashi M; Ishibashi M; Sunazuka T; Izuhara T; Sugahara K; Tsuruda K; Masuda M; Takasu N; Tsukasaki K; Tomonaga M; Kamihira S
    Blood; 2007 Sep; 110(5):1664-74. PubMed ID: 17551094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis.
    Ishibashi M; Ohtsuki T
    Med Res Rev; 2008 Sep; 28(5):688-714. PubMed ID: 18273883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valosin-containing Protein is a Target of 5'-l Fuligocandin B and Enhances TRAIL Resistance in Cancer Cells.
    Arai MA; Taguchi S; Komatsuzaki K; Uchiyama K; Masuda A; Sampei M; Satoh M; Kado S; Ishibashi M
    ChemistryOpen; 2016 Dec; 5(6):574-579. PubMed ID: 28032027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.
    Wang G; Zhan Y; Wang H; Li W
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):799-805. PubMed ID: 22037880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules.
    Hwang MK; Ryu BJ; Kim SH
    Amino Acids; 2012 Oct; 43(4):1679-87. PubMed ID: 22354145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanisms of TRAIL resistance in cancer cells: help in designing new drugs.
    Wang F; Lin J; Xu R
    Curr Pharm Des; 2014; 20(42):6714-22. PubMed ID: 25269558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
    Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.
    Dai X; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
    Exp Biol Med (Maywood); 2015 Jun; 240(6):760-73. PubMed ID: 25854879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancer.
    Braig S; Bischoff F; Abhari BA; Meijer L; Fulda S; Skaltsounis L; Vollmar AM
    Biochem Pharmacol; 2014 Sep; 91(2):157-67. PubMed ID: 25069048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.
    Pal S; Shankar BS; Sainis KB
    Cytokine; 2013 Oct; 64(1):196-207. PubMed ID: 23972545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
    Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
    Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
    He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
    Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
    Vega MI; Baritaki S; Huerta-Yepez S; Martinez-Paniagua MA; Bonavida B
    Leuk Lymphoma; 2011 Jan; 52(1):108-21. PubMed ID: 21133714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
    Pathil A; Armeanu S; Venturelli S; Mascagni P; Weiss TS; Gregor M; Lauer UM; Bitzer M
    Hepatology; 2006 Mar; 43(3):425-34. PubMed ID: 16583461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS
    Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.
    Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H
    Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.